Crigler-Najjar syndrome (Q40115): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
A síndrome de Crigler-Najjar é um distúrbio autossômico recessivo do metabolismo da bilirrubina, caracterizado por hiperbilirrubinemia não conjugada(bilirrubina indireta) devido a um déficit hepático da atividade da bilirrubina glucuronosiltransferase. Dois tipos foram descritos, SCN tipos 1 e 2, dependendo se o déficit enzimático é completo ou parcial: as manifestações clínicas variam de acordo. Os pacientes apresentam icterícia isolada que aparece no início da vida. As análises biológicas detectam hiperbilirrubinemia não conjugada grave com testes de função hepática normais. Os estudos de imagem abdominal (radiografias simples, tomografias computadorizadas ou ultrassonografias) e os achados da histologia hepática são normais. O diagnóstico geralmente é confirmado por análise de DNA genômico.
description / endescription / en
 
Crigler-Najjar syndrome is an autosomal recessive disorder of bilirubin metabolism characterised by unconjugated hyperbilirubinemia due to a hepatic deficit of bilirubin glucuronosyltransferase activity. Two types have been described, CNS types 1 and 2, depending on whether the enzymatic deficit is complete or partial: clinical manifestations vary accordingly. Patients present with isolated jaundice that appears early in life. Biological analyses detect severe unconjugated hyperbilirubinemia with normal liver function tests. Abdominal imaging studies (plain X-rays, CT scans or ultrasonograms) and liver histology findings are normal. Diagnosis is generally confirmed by genomic DNA analysis.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/291439191 / rank
 
Normal rank
Property / CURIE
 
CID11:5C58.00
Property / CURIE: CID11:5C58.00 / rank
 
Normal rank
Property / Canary Token
 
dki-india-5C58.00
Property / Canary Token: dki-india-5C58.00 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: E80.5 / rank
 
Normal rank

Latest revision as of 05:47, 13 August 2026

Crigler-Najjar syndrome is an autosomal recessive disorder of bilirubin metabolism characterised by unconjugated hyperbilirubinemia due to a hepatic deficit of bilirubin glucuronosyltransferase activity. Two types have been described, CNS types 1 and 2, depending on whether the enzymatic deficit is complete or partial: clinical manifestations vary accordingly. Patients present with isolated jaundice that appears early in life. Biological analyses detect severe unconjugated hyperbilirubinemia with normal liver function tests. Abdominal imaging studies (plain X-rays, CT scans or ultrasonograms) and liver histology findings are normal. Diagnosis is generally confirmed by genomic DNA analysis.
Language Label Description Also known as
default for all languages
5C58.00
    English
    Crigler-Najjar syndrome
    Crigler-Najjar syndrome is an autosomal recessive disorder of bilirubin metabolism characterised by unconjugated hyperbilirubinemia due to a hepatic deficit of bilirubin glucuronosyltransferase activity. Two types have been described, CNS types 1 and 2, depending on whether the enzymatic deficit is complete or partial: clinical manifestations vary accordingly. Patients present with isolated jaundice that appears early in life. Biological analyses detect severe unconjugated hyperbilirubinemia with normal liver function tests. Abdominal imaging studies (plain X-rays, CT scans or ultrasonograms) and liver histology findings are normal. Diagnosis is generally confirmed by genomic DNA analysis.

      Statements

      CID11:5C58.00
      0 references
      dki-india-5C58.00
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references